Russia's Cancer Vaccine Shows 100% Efficacy in Clinical Trials

story

1 day ago

Image copyright: Russia's National Medical Research Radiological Centre

story last updated 1 day ago

The Spin

Narrative A

This breakthrough is a revolutionary leap in cancer treatment that could save countless lives worldwide. The 100% efficacy rate in human trials demonstrates that mRNA technology can be successfully adapted beyond COVID vaccines to treat cancer with unprecedented precision and safety.

RT NDTV

Narrative B

Early trial success doesn't guarantee long-term effectiveness, and the small sample size of 48 volunteers raises questions about broader applicability. Significant logistical challenges, including personalized vaccine production, cold-chain storage, and genomic profiling, must be addressed before this becomes viable. Much more study is needed — especially for mRNA technology.

Tribune India NCBI